Literature DB >> 27158816

The dilemma of systemic steroids in preschool children with recurrent wheezing exacerbations.

Deepti R Deshpande1, Fernando D Martinez2.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27158816     DOI: 10.1002/ppul.23465

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


× No keyword cloud information.
  4 in total

Review 1.  Management of preschool recurrent wheezing and asthma: a phenotype-based approach.

Authors:  Avraham Beigelman; Leonard B Bacharier
Journal:  Curr Opin Allergy Clin Immunol       Date:  2017-04

2.  Challenges in assessing the efficacy of systemic corticosteroids for severe wheezing episodes in preschool children.

Authors:  Theresa W Guilbert; Leonard B Bacharier; David T Mauger; Wanda Phipatanakul; Stanley J Szefler; Susan Boehmer; Avraham Beigelman; Anne M Fitzpatrick; Daniel J Jackson; Sachin N Baxi; Mindy Benson; Carey-Ann D Burnham; Michael D Cabana; Mario Castro; James F Chmiel; Ronina Covar; Michael Daines; Jonathan M Gaffin; Deborah A Gentile; Fernando Holguin; Elliot Israel; H William Kelly; Stephen C Lazarus; Robert F Lemanske; Ngoc Ly; Kelley Meade; Wayne Morgan; James Moy; J Tod Olin; Stephen P Peters; Jacqueline A Pongracic; Hengameh H Raissy; Kristie Ross; William J Sheehan; Christine Sorkness; W Gerald Teague; Shannon Thyne; Fernando D Martinez
Journal:  J Allergy Clin Immunol       Date:  2019-01-17       Impact factor: 10.793

Review 3.  Predicting Severe Asthma Exacerbations in Children.

Authors:  Sandeep Puranik; Erick Forno; Andrew Bush; Juan C Celedón
Journal:  Am J Respir Crit Care Med       Date:  2017-04-01       Impact factor: 21.405

Review 4.  Management of acute respiratory diseases in the pediatric population: the role of oral corticosteroids.

Authors:  Renato Cutrera; Eugenio Baraldi; Luciana Indinnimeo; Michele Miraglia Del Giudice; Giorgio Piacentini; Francesco Scaglione; Nicola Ullmann; Laura Moschino; Francesca Galdo; Marzia Duse
Journal:  Ital J Pediatr       Date:  2017-03-23       Impact factor: 2.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.